VIVI (VIVI) News
Follow VIVI (VIVI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
TempraMed Technologies Ltd. (VIVI) Signs LOI for Exclusive Cyprus Distribution
TempraMed signed a non-binding LOI to appoint CPO Cyprus as exclusive distributor of VIVI Cap and VIVI Epi in Cyprus, subject to a definitive agreement and minimum purchase terms including 20% YoY growth to maintain excl
NEWS | Sep 29, 2026, 07:08 AM UTC
L
TempraMed Signs Letter of Intent with CPO Cyprus for Exclusive Distribution of VIVI Products in Cyprus
Distribution partnership with one of Cyprus's most established healthcare and consumer-products distributorsHighlights:Toronto, Ontario--(. - September 29, 2026) - TempraMed Technologies Ltd. CSE:VIVI (FSE: 9DY) (OTCQB:
NEWS | Sep 29, 2026, 07:08 AM UTC
L
TempraMed Technologies Ltd. (VIVI) Expands LATAM TEM Deal, Plans C$1.0M Private Placement
TempraMed amended its TEM distribution to add Argentina, Venezuela, Colombia and Costa Rica, received another commercial order, and launched a non-brokered private placement of up to C$1.0M at C$0.50/unit with 18—month C
NEWS | Sep 24, 2026, 07:01 AM UTC
L
TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement
Amendment extends TEM relationship beyond Panama into additional Latin American markets, adds VIVI Med(TM) to the distribution framework, and supports broader regional availability following product registrationsHighligh
NEWS | Sep 24, 2026, 07:01 AM UTC
L
TempraMed Technologies Ltd. (VIVI) Signs Distribution Deal With CenterWell Pharmacy
TempraMed signed a distribution agreement with CenterWell Pharmacy, Humana’s pharmacy services brand, for anticipated distribution of VIVI Cap and VIVI Epi. The deal has no minimum purchase commitments and may be termina
NEWS | Sep 23, 2026, 07:11 AM UTC
L
TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana
Toronto, Ontario--(. - September 23, 2026) - TempraMed Technologies Ltd. CSE:VIVI (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medication
NEWS | Sep 23, 2026, 07:11 AM UTC
M
TempraMed reports record July sales and strong August performance
TempraMed says July sales were US$522K and August sales were US$403K. It also reports first-eight-month 2026 sales of US$2.07M, exceeding total 2025 sales of US$1.8M.
EQUITY | Sep 18, 2026, 08:51 PM UTC
L
TempraMed signs LOI for exclusive Greece distribution of VIVI products
TempraMed Technologies Ltd. signed a letter of intent with CPO Greece for an exclusive distribution framework covering TempraMed’s injectable medication-protection products across Greece, linked to VIVI products.
EQUITY | Sep 01, 2026, 10:46 AM UTC